A Comprehensive HIV Prevention Package for South African Adolescent Girls and Young Women: IMARA SA
- Conditions
- HivSexually Transmitted Infection
- Registration Number
- NCT05504954
- Lead Sponsor
- University of Illinois at Chicago
- Brief Summary
Programs which go beyond individual-level behavior change to reduce HIV and STI infections among adolescent girls and young women in sub-Saharan Africa are essential to meet global HIV targets. Informed, Motivated, Aware and Responsible Adolescents and Adults- South Africa (IMARA-SA) is an evidence-based HIV-prevention intervention for adolescent girls and young women (AGYW) and their female caregivers, which has been adapted for a South African audience. This pilot study will assess feasibility in preparation for a randomized controlled trial (RCT). Additionally, the pilot will examine the preliminary effectiveness of IMARA-SA in reducing sexually transmitted infections (STI) and increasing uptake of HIV testing and counseling (HTC) and pre-exposure prophylaxis (PrEP) at follow-up among AGYW. About 60 AGYW-FC dyads will be enrolled and randomized to IMARA-SA or a health-promotion control arm. Following randomization, the dyads will participate in an \~2-day group workshop (\~10 hours), which includes joint and separate mother and daughter activities. AGYW and FC will complete baseline assessments and follow-up assessments approximately 6 months later. Assessments will include surveys, STIs testing (for chlamydia and gonorrhea), and uptake of HTC and a 1-month PrEP prescription. Additionally, the intervention's implementation (e.g., acceptability) will be explored.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 61
Not provided
AGYW will be excluded from the study if they do not have a FC to participate in the study.
AGYW and FC will be excluded from the study if they:
- are unable to understand the consent/assent process and provide written informed consent;
- are currently enrolled in another research study addressing HIV/STIs/PrEP;
- participated in the IMARA-SA adaptation process. AGYW and FC must agree to participate as a dyad. AGYW refusal will supersede FC consent.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Number of AGYW Who Tested Positive for a Sexually Transmitted Infection (STI) 8-17 months post baseline A positive test for at least one of two STIs: chlamydia and/or gonorrhea
Number of AGYW Completing HIV Testing and Counseling (HTC) 8-17 months post baseline Completion of HIV Testing and Counseling (HTC)
Number of AGYW Who Elected to Take Pre-Exposure Prophylaxis (PrEP) 8-17 months post baseline Uptake of Pre-Exposure Prophylaxis (PrEP) assessed as receipt of PrEP prescription from research team or other care provider after the baseline survey.
- Secondary Outcome Measures
Name Time Method AGYW Condom Use at Last Sex 6-10 months post baseline Self-reported condom use at last vaginal or anal sex using the AIDS Risk Behavior Assessment (ARBA).
AGYW Consistency of Condom Use 6-10 months post baseline Self-reported consistency of condom use during vaginal and anal sex in the past 6-months using the AIDS Risk Behavior Assessment (ARBA).
AGYW Substance Use During Sex in the Past 6 Months 6-10 months post baseline Self-reported number of times had vaginal or anal sex while drinking or taking drugs in the past 6-months using the AIDS Risk Behavior Assessment (ARBA).
Number of Partners in the Past 6 Months 6-10 months post baseline Self-reported number of vaginal or anal sex partners in the past 6-months using the AIDS Risk Behavior Assessment (ARBA).
AGYW's Report of Adherence to PrEP 6-10 months post baseline Adherence to PrEP is measured using an adapted version of the Wilson scale (2017).
Measure Description: (0=low adherence to 100=high adherence) Scale is comprised of 3 items: number of days dose missed, how often did you take PrEP in the way you were supposed to, how good a job did you do at taking PrEP.
Items were transformed to a 0-100 scale and averaged. Thirty was subtracted from number of days missed and multiplied by 3.33. Responses for remaining 2 items: never/very poor=0, rarely/poor=20, sometimes/fair=40, usually/good=60, almost always/very good=80, always/excellent=100.
Trial Locations
- Locations (1)
Desmond Tutu HIV Centre
🇿🇦Cape Town, Western Cape, South Africa
Desmond Tutu HIV Centre🇿🇦Cape Town, Western Cape, South Africa
